BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 33176578)

  • 1. Targeting Mitochondria-Inflammation Circuit by β-Hydroxybutyrate Mitigates HFpEF.
    Deng Y; Xie M; Li Q; Xu X; Ou W; Zhang Y; Xiao H; Yu H; Zheng Y; Liang Y; Jiang C; Chen G; Du D; Zheng W; Wang S; Gong M; Chen Y; Tian R; Li T
    Circ Res; 2021 Jan; 128(2):232-245. PubMed ID: 33176578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dapagliflozin Attenuates Heart Failure With Preserved Ejection Fraction Remodeling and Dysfunction by Elevating β-Hydroxybutyrate-activated Citrate Synthase.
    Zhang X; Wang N; Fu P; An Y; Sun F; Wang C; Han X; Zhang Y; Yu X; Liu Y
    J Cardiovasc Pharmacol; 2023 Nov; 82(5):375-388. PubMed ID: 37643027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Gα oxidation.
    Kolijn D; Pabel S; Tian Y; Lódi M; Herwig M; Carrizzo A; Zhazykbayeva S; Kovács Á; Fülöp GÁ; Falcão-Pires I; Reusch PH; Linthout SV; Papp Z; van Heerebeek L; Vecchione C; Maier LS; Ciccarelli M; Tschöpe C; Mügge A; Bagi Z; Sossalla S; Hamdani N
    Cardiovasc Res; 2021 Jan; 117(2):495-507. PubMed ID: 32396609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study protocol, randomized controlled trial: reducing symptom burden in patients with heart failure with preserved ejection fraction using ubiquinol and/or D-ribose.
    Pierce JD; Mahoney DE; Hiebert JB; Thimmesch AR; Diaz FJ; Smith C; Shen Q; Mudaranthakam DP; Clancy RL
    BMC Cardiovasc Disord; 2018 Apr; 18(1):57. PubMed ID: 29606104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NLRP3-inflammasome inhibition by MCC950 attenuates cardiac and pulmonary artery remodelling in heart failure with preserved ejection fraction.
    Cheng X; Zhao H; Wen X; Li G; Guo S; Zhang D
    Life Sci; 2023 Nov; 333():122185. PubMed ID: 37858713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockout of MD1 contributes to sympathetic hyperactivity and exacerbates ventricular arrhythmias following heart failure with preserved ejection fraction via NLRP3 inflammasome activation.
    Yang HJ; Kong B; Shuai W; Zhang JJ; Huang H
    Exp Physiol; 2020 Jun; 105(6):966-978. PubMed ID: 32240565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial Dysfunction in Heart Failure With Preserved Ejection Fraction.
    Kumar AA; Kelly DP; Chirinos JA
    Circulation; 2019 Mar; 139(11):1435-1450. PubMed ID: 30856000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mtDNA repair fusion protein attenuates maladaptive remodeling and preserves cardiac function in heart failure.
    Bradley JM; Li Z; Organ CL; Polhemus DJ; Otsuka H; Islam KN; Bhushan S; Gorodnya OM; Ruchko MV; Gillespie MN; Wilson GL; Lefer DJ
    Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H311-H321. PubMed ID: 29101177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choline ameliorates cardiac hypertrophy by regulating metabolic remodelling and UPRmt through SIRT3-AMPK pathway.
    Xu M; Xue RQ; Lu Y; Yong SY; Wu Q; Cui YL; Zuo XT; Yu XJ; Zhao M; Zang WJ
    Cardiovasc Res; 2019 Mar; 115(3):530-545. PubMed ID: 30165480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart Failure With Preserved Ejection Fraction Induces Beiging in Adipose Tissue.
    Valero-Muñoz M; Li S; Wilson RM; Hulsmans M; Aprahamian T; Fuster JJ; Nahrendorf M; Scherer PE; Sam F
    Circ Heart Fail; 2016 Jan; 9(1):e002724. PubMed ID: 26721917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic inflammation in heart failure with preserved ejection fraction.
    Schiattarella GG; Rodolico D; Hill JA
    Cardiovasc Res; 2021 Jan; 117(2):423-434. PubMed ID: 32666082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronically Elevating Circulating Ketones Can Reduce Cardiac Inflammation and Blunt the Development of Heart Failure.
    Byrne NJ; Soni S; Takahara S; Ferdaoussi M; Al Batran R; Darwesh AM; Levasseur JL; Beker D; Vos DY; Schmidt MA; Alam AS; Maayah ZH; Schertzer JD; Seubert JM; Ussher JR; Dyck JRB
    Circ Heart Fail; 2020 Jun; 13(6):e006573. PubMed ID: 32493060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SIRT5-Related Desuccinylation Modification Contributes to Quercetin-Induced Protection against Heart Failure and High-Glucose-Prompted Cardiomyocytes Injured through Regulation of Mitochondrial Quality Surveillance.
    Chang X; Zhang T; Wang J; Liu Y; Yan P; Meng Q; Yin Y; Wang S
    Oxid Med Cell Longev; 2021; 2021():5876841. PubMed ID: 34603599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insight into the Pro-inflammatory and Profibrotic Role of Macrophage in Heart Failure With Preserved Ejection Fraction.
    Shen JL; Xie XJ
    J Cardiovasc Pharmacol; 2020 Sep; 76(3):276-285. PubMed ID: 32501838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin improves cardiac function in mice with heart failure after myocardial infarction by regulating mitochondrial energy metabolism.
    Sun D; Yang F
    Biochem Biophys Res Commun; 2017 Apr; 486(2):329-335. PubMed ID: 28302481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extreme Acetylation of the Cardiac Mitochondrial Proteome Does Not Promote Heart Failure.
    Davidson MT; Grimsrud PA; Lai L; Draper JA; Fisher-Wellman KH; Narowski TM; Abraham DM; Koves TR; Kelly DP; Muoio DM
    Circ Res; 2020 Sep; 127(8):1094-1108. PubMed ID: 32660330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs That Ameliorate Epicardial Adipose Tissue Inflammation May Have Discordant Effects in Heart Failure With a Preserved Ejection Fraction as Compared With a Reduced Ejection Fraction.
    Packer M
    J Card Fail; 2019 Dec; 25(12):986-1003. PubMed ID: 31541742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial protein hyperacetylation underpins heart failure with preserved ejection fraction in mice.
    Liu X; Zhang Y; Deng Y; Yang L; Ou W; Xie M; Ding L; Jiang C; Yu H; Li Q; Li T
    J Mol Cell Cardiol; 2022 Apr; 165():76-85. PubMed ID: 34998831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes. Further Augmentation of the Effects with Saxagliptin, a DPP4 Inhibitor.
    Ye Y; Bajaj M; Yang HC; Perez-Polo JR; Birnbaum Y
    Cardiovasc Drugs Ther; 2017 Apr; 31(2):119-132. PubMed ID: 28447181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca
    Suetomi T; Willeford A; Brand CS; Cho Y; Ross RS; Miyamoto S; Brown JH
    Circulation; 2018 Nov; 138(22):2530-2544. PubMed ID: 30571348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.